Cargando…
Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells
Sorafenib, a tyrosine kinase inhibitor, has been demonstrated to exert anti-tumor effects. However, the molecular mechanisms underlying its effects on bladder cancer remain unknown. Here, we evaluated the mechanisms responsible for the sorafenib-induced anti-tumor effects on 5637 and T24 bladder can...
Autores principales: | Amantini, Consuelo, Morelli, Maria Beatrice, Santoni, Matteo, Soriani, Alessandra, Cardinali, Claudio, Farfariello, Valerio, Eleuteri, Anna Maria, Bonfili, Laura, Mozzicafreddo, Matteo, Nabissi, Massimo, Cascinu, Stefano, Santoni, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468325/ https://www.ncbi.nlm.nih.gov/pubmed/26097873 |
Ejemplares similares
-
Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells
por: Santoni, M, et al.
Publicado: (2013) -
The TRPV1 ion channel regulates thymocyte differentiation by modulating autophagy and proteasome activity
por: Amantini, Consuelo, et al.
Publicado: (2017) -
Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells
por: Morelli, Maria Beatrice, et al.
Publicado: (2015) -
Capsaicin triggers autophagic cell survival which drives epithelial mesenchymal transition and chemoresistance in bladder cancer cells in an Hedgehog-dependent manner
por: Amantini, Consuelo, et al.
Publicado: (2016) -
Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128
por: Liberati, Sonia, et al.
Publicado: (2014)